
Diabetic patients are more susceptible to severe COVID-19 outcomes.

Dr. Kausik Ray presents new data on inclisiran and bempedoic acid as cholesterol lowering medications.

A pediatric dermatologist discusses dupilumab for pediatric atopic dermatitis in addition to promising new therapies.

A uveitis specialist breaks down what occurs during the uveitis-dedicated event and comments on its importance.

A new IRIS registry analysis reports that many patients with geographic atrophy do not continue follow-up after initial visit or consultation.

Girish Hiremath, MD, MPH, discusses a need to more accurately and objectively assess pediatric compliance to eosinophilic esophagitis therapies.

The CDC has standardized guidelines to help diagnose diarrhea, a potential indicator of c. difficile infection.

Benjamin Noor, MD, discusses a recent study from ACG that demonstrated that EBTs are associated with improved parameters for weight loss and diabetes.

An expert discusses a study assessing the effects of low compliance to eosinophilic esophagitis therapies among pediatric patients.

Brad Glick gives an overview of new and exciting trends in the field of dermatology.

Brad Glick, DO, FAAD, previews a few of the topics that will be discussed on Derm Discussions, HCPLive's new expert-led skin health podcast series.

The host of HCPLive's new derm podcast series discusses what to expect as well as the importance of multimedia medical news.

An expert offers 5 tips to physicians and patients on best practices for managing symptoms related to allergic asthma.

Paul Christo, MD, discusses opioid addiction during the pandemic, the role of the clinician, and offers a hopeful outlook for the future.

An expert discusses trends in pediatric mental health and receipt of treatment.

An expert discusses steps the FDA can take to strengthen and make more airtight their process for approving new opioids.

An expert discusses the effect the pandemic has had on opioid use and related deaths.

A pharmacoepidemiologist offers his comments on the ongoing opioid epidemic.

An expert discusses how allergies can make it easier for viruses to enter the body as well as the association between asthma and COVID-19 severity.

For many patients suffering from depression or anxiety, the added stress of the pandemic has led to a medication change.

Educating patients of the immune system can be helpful in addressing any concerns over getting vaccinated for the flu.

An expert discusses the importance of getting vaccinated for the flu this year as well as strategies healthcare systems are taking to ensure easy access for patients.

Pulmonary conditions like asthma could often lead to the development of chronic cough.

Despite not being able to attend conferences live, there are some advantages to a virtual conference.

Asthma patients have not had higher rates of negative outcomes from COVID-19 than other individuals.

The biologic drug is set to be used as a combination therapy for asthma.

It has been approximately 60 years since a new treatment for coughs has come on the market.

Obese-related asthma is considered one of the more severe asthma phenotypes.

Telemedicine has become an important tool during the COVID-19 pandemic.

Problems using inhalers correctly is an ongoing issue for both pediatric and adult patients.